Radiofrequency treatment for chronic plantar fasciitis
Effect of Radiofrequency Treatments on Foot Functionality Index, Patient Satisfaction and Pain Scores in Plantar Fasciitis Patients
This study is testing if a new radiofrequency treatment can help adults with chronic heel pain from plantar fasciitis feel better and improve their daily activities.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 108 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Ankara University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Ankara) |
| Trial ID | NCT06426667 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of radiofrequency therapy applied to the posterior tibial nerve and calcaneal spur area in adults suffering from chronic plantar fasciitis. Using ultrasound guidance, the study aims to assess improvements in patient satisfaction, pain levels, and functional outcomes. Chronic plantar fasciitis is a common cause of heel pain, and this approach seeks to provide a less invasive alternative to surgery. The study will include patients who have not responded to conservative treatments and have been experiencing heel pain for at least six months.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with chronic heel pain due to plantar fasciitis lasting at least six months.
Not a fit: Patients with a history of trauma, certain chronic diseases, or previous treatments for heel pain may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce pain and improve function for patients with chronic plantar fasciitis.
How similar studies have performed: Previous studies have shown that radiofrequency therapy can be effective for chronic plantar heel pain, although this specific approach using ultrasound guidance is less commonly tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-65 years old, * Heel pain for at least 6 months and a diagnosis of plantar fasciitis confirmed by direct radiography and physical examination, * Visual analog scale is 4 or more * No response to conservative treatment (medical and physical medicine modalities) Exclusion Criteria: * History of trauma or calcaneus fracture, * Osteoarthritis, Diabetes mellitus, chronic heart disease * Presence of pregnancy, * Pain due to peripheral neuropathy or ischemia * Inability to tolerate injections in the heel area, * Allergy to local anesthetics or steroids, * Presence of an open wound on the side of the foot that the injection will be performed * Local or systemic infection at the time of the procedure * Previous steroid injection, radiofrequency application or ESWT (electroshock wave) treatment into the heel * History of surgical intervention to the heel * Presence of any functional limitation in the affected foot * Presence of neurological, hepatic and/or metabolic diseases; dermatological infections, seronegative spondyloarthropathy, bleeding diathesis * Failure to discontinue anticoagulant or antiaggregant within the specified periods * Absence of follow-up throughout the study.
Where this trial is running
Ankara
- Ankara University — Ankara, Turkey (Recruiting)
Study contacts
- Study coordinator: Hanzade A Unal, MD
- Email: hanzadeunal@windowslive.com
- Phone: +905057179039
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.